Literature DB >> 20456301

Body mass index, chronic atrophic gastritis and heartburn: a population-based study among 8936 older adults from Germany.

L Gao1, M N Weck, D Rothenbacher, H Brenner.   

Abstract

BACKGROUND: Obesity and overweight have been positively related to gastro-oesophageal reflux disease (GERD). It has been suggested that this relationship is as a consequence of an increased gastric acid reflux, which is caused by an enhanced intra-abdominal pressure. AIM: To assess potential interaction of the association between body mass index (BMI) and GERD by chronic atrophic gastritis, which goes along with decreased acid production.
METHODS: In the baseline examination of ESTHER, a study conducted in 9953 older adults in Saarland, information on frequency of heartburn, potential risk factors and medical history was obtained by self-administered standardized questionnaire. Serological measurements of pepsinogen I and II were taken for definition of chronic atrophic gastritis.
RESULTS: In total, 2565 (28.7%) of the included subjects experienced heartburn within the previous 4 weeks. A pronounced dose-response relationship was observed between BMI and heartburn occurrence (P < 0.001) among people without chronic atrophic gastritis, but not among people with chronic atrophic gastritis (P-value for interaction = 0.018). Obese/overweight people with chronic atrophic gastritis had a much lower risk of heartburn compared with obese/overweight people without chronic atrophic gastritis (OR = 0.31, 95% CI = 0.24-0.40).
CONCLUSION: Our results are consistent with the hypothesis that BMI is related positively to GERD symptoms by its impact on acid reflux.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456301     DOI: 10.1111/j.1365-2036.2010.04334.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium.

Authors:  Cathrine Hoyo; Michael B Cook; Farin Kamangar; Neal D Freedman; David C Whiteman; Leslie Bernstein; Linda M Brown; Harvey A Risch; Weimin Ye; Linda Sharp; Anna H Wu; Mary H Ward; Alan G Casson; Liam J Murray; Douglas A Corley; Olof Nyrén; Nirmala Pandeya; Thomas L Vaughan; Wong-Ho Chow; Marilie D Gammon
Journal:  Int J Epidemiol       Date:  2012-11-12       Impact factor: 7.196

3.  Atrophic gastritis is inversely associated with gastroesophageal reflux disease in a twin register based study.

Authors:  Ji Zhang; Rino Bellocco; Joar Franzén; Ulrika Zagai; Patrik K E Magnusson; Weimin Ye
Journal:  United European Gastroenterol J       Date:  2022-06-22       Impact factor: 6.866

4.  Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals.

Authors:  Farhad Islami; Siavosh Nasseri-Moghaddam; Akram Pourshams; Hossein Poustchi; Shahryar Semnani; Farin Kamangar; Arash Etemadi; Shahin Merat; Masoud Khoshnia; Sanford M Dawsey; Paul D Pharoah; Paul Brennan; Christian C Abnet; Paolo Boffetta; Reza Malekzadeh
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

5.  TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.

Authors:  Gillian Watson; James O'Hara; Paul Carding; Jan Lecouturier; Deborah Stocken; Tony Fouweather; Janet Wilson
Journal:  Trials       Date:  2016-04-01       Impact factor: 2.279

6.  The morbidity rate of chronic disease among Chinese rural residents: results from Liuyang cohort.

Authors:  Xin Huang; Mengshi Chen; Hongzhuan Tan; Shuiyuan Xiao; Jing Deng
Journal:  Med Princ Pract       Date:  2013-01-25       Impact factor: 1.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.